Humanigen Inc (HGEN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access HGEN Annual Balance Sheets →
Looking at balance sheet data from Humanigen Inc through Mar 31 2022 provides insight into Mar 31 2023's solvency and capital structure over time.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2023)
(Dec 31 2022) (Sep 30 2022) (Jun 30 2022) (Mar 31 2022)
Assets
Cash & cash equivalent3.10
Cash & Short-term Investments3.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.93
Total Current Assets5.03
Other Assets, Noncurrent0.09
Total Assets5.12
Liabilities
Accounts Payable, Current AC38.39
Accrued Liabilities, Current AC14.02
Long-term Debt, Current Maturities LO0.00
Deferred Revenue, Current DE0.88
Total Current Liabilities53.30
Long-term debt0.00
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE1.55
Other liabilities, Noncurrent0.00
Total Liabilities54.84
Stockholders' Equity
Common Stock Value0.12
Additional Paid In Capital Common Stock636.15
Retained Earnings / Accumulated Deficit-685.99
Other Equity0.00
Common Stockholder's Equity-49.73
Total Stockholder's Equity-49.73
Liabilities & Stockholder's Equity5.12
4 historic quarters locked

Sign in to unlock the full Humanigen Inc balance sheet history.

About Humanigen Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001214659-23-007002

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.